DrugPatentWatch Database Preview
NOVOLOG FLEXTOUCH Drug Profile
Which patents cover Novolog Flextouch, and when can generic versions of Novolog Flextouch launch?
Novolog Flextouch is a drug marketed by Novo Nordisk Inc and is included in one NDA. There are thirteen patents protecting this drug.
The generic ingredient in NOVOLOG FLEXTOUCH is insulin aspart recombinant. There are forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the insulin aspart recombinant profile page.
Summary for NOVOLOG FLEXTOUCH
| US Patents: | 13 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NOVOLOG FLEXTOUCH |
| DailyMed Link: | NOVOLOG FLEXTOUCH at DailyMed |
Pharmacology for NOVOLOG FLEXTOUCH
| Ingredient-type | Insulin |
| Drug Class | Insulin Analog |
Medical Subject Heading (MeSH) Categories for NOVOLOG FLEXTOUCH
US Patents and Regulatory Information for NOVOLOG FLEXTOUCH
Expired US Patents for NOVOLOG FLEXTOUCH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc | NOVOLOG FLEXTOUCH | insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 020986-005 | Oct 31, 2013 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Novo Nordisk Inc | NOVOLOG FLEXTOUCH | insulin aspart recombinant | INJECTABLE;SUBCUTANEOUS | 020986-005 | Oct 31, 2013 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for NOVOLOG FLEXTOUCH
| Country | Document Number | Estimated Expiration |
|---|---|---|
| South Korea | 101278123 | ➤ Try a Free Trial |
| Japan | 5558477 | ➤ Try a Free Trial |
| Japan | 4698677 | ➤ Try a Free Trial |
| South Korea | 101300496 | ➤ Try a Free Trial |
| Russian Federation | 2007126416 | ➤ Try a Free Trial |
| Israel | 182616 | ➤ Try a Free Trial |
| Japan | 5568157 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for NOVOLOG FLEXTOUCH
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 0883 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: INSULIN GLARGINE/LIXISENATIDE; REGISTRATION NO/DATE: EU/1/16/1157 20170113 |
| 13/034 | Ireland | ➤ Try a Free Trial | APPLICATION FOR EXTENSION OF THE DURATION OF A SUPPLEMENTARY PROTECTION CERTIFICATE 2013/034 IN JOURNAL NO. 2325 OF 25/01/2017 UNDER THE HEADING APPLICATION FOR EXTENSION OF THE DURATION OF A SUPPLEMENTARY PROTECTION CERTIFICATE, SPC NO. 2013/034 SHOULD HAVE APPEARED AS FOLLOWS, NOVO NORDISK A/S NOVO ALLE, 2880 BAGSVAERD, DENMARK (20/12/2016) PATENT NO: EP2107069; NOVEL INSULIN DERIVATIVES PRODUCT: INSULIN DEGLUDEC MARKET AUTHORISATION: EU: EU/1/12/807-001, 004, 005, 007-009, 012, 013 AND 015 (21/01/2013) ORIGINAL SPC EXPIRY DATE: 22/01/2028 1127 DESIGNS REGISTERED UNDER THE INDUSTRIAL DESIGNS ACT, 2001 |
| C/GB05/024 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: INSULIN GLULISINE OR A PHYSIOLOGICALLY TOLERABLE SALT THEREOF; REGISTRATION NO/DATE: EU/1/04/285/001 - 020 20040929 |
| 91022-0 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: N EPSILONB29 MYRISTOYL- ELLER N EPSILONB29 TETRADEKANOYL-DES(B30) HUMANT INSULIN |
| 00019 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: INSULINE GLARGINE,DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH GESCHIKT ZOUT; REGISTRATION NO/DATE: EU/1/00/134/001 - 007 20000609 |
| 90067-4 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE; REG. NO/DATE: EU/1/14/974 20140918 |
| C0035 | France | ➤ Try a Free Trial | PRODUCT NAME: INSULINE DEGLUDEC; REGISTRATION NO/DATE: EU/1/12/807/001 20130121 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
